These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8036356)

  • 21. Hypomagnesemia. Suppression of secondary hyperparathyroidism in chronic renal failure.
    Miller PD; Krebs RA; Neal BJ; McIntyre DO
    JAMA; 1979 Feb; 241(7):722-3. PubMed ID: 762831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic background of uremic secondary hyperparathyroidism.
    Aucella F; Morrone L; Stallone C; Gesualdo L
    J Nephrol; 2005; 18(5):537-47. PubMed ID: 16299679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between parathormone and 1,25-dihydroxyvitamin D3 in chronic kidney failure].
    Sotorník I
    Vnitr Lek; 1997 Sep; 43(9):615-9. PubMed ID: 9750473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uremia: formulations and expectations. The trade-off hypothesis: current status.
    Bricker NS; Fine LG
    Kidney Int Suppl; 1978 Jun; (8):S5-8. PubMed ID: 278898
    [No Abstract]   [Full Text] [Related]  

  • 25. Uremic cardiomyopathy: role of parathyroid hormone.
    Smogorzewski M; Massry SG
    Kidney Int Suppl; 1997 Nov; 62():S12-4. PubMed ID: 9350671
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary parathyroid hormone-like activity in patients with uremia.
    Bethune JE; Chakmakjian ZH; Turpin RA
    Arch Intern Med; 1969 Oct; 124(4):423-5. PubMed ID: 5823013
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
    Kawata T; Imanishi Y; Kobayashi K; Tahara H; Ishimura E; Inaba M; Nishizawa Y; Takemoto Y; Onoda N; Okuno S; Ishikawa T
    Clin Calcium; 2005 Sep; 15 Suppl 1():98-100; discussion 100-1. PubMed ID: 16279017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uremia, parathyroid hormone and carbohydrate intolerance.
    Massry SG
    Contrib Nephrol; 1986; 50():96-108. PubMed ID: 3542374
    [No Abstract]   [Full Text] [Related]  

  • 29. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL; González Suárez I; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure.
    Tominaga Y; Sato K; Tanaka Y; Numano M; Uchida K; Takagi H
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S42-7. PubMed ID: 8608662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathormone as a nerve poison in uremia.
    Di Giulio S; Chkoff N; Lhoste F; Zingraff J; Drüeke T
    N Engl J Med; 1978 Nov; 299(20):1134-5. PubMed ID: 703796
    [No Abstract]   [Full Text] [Related]  

  • 32. Osmotic fragility of red blood cells, secondary hyperparathyroidism, and uremia.
    Massry SG; Akmal M
    Nephron; 1986; 43(1):70-1. PubMed ID: 3703069
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid hormone as a uremic toxin.
    Molzahn AE
    J Nephrol Nurs; 1984; 1(1):13-6. PubMed ID: 6565766
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium metabolism in patients with chronic uremia.
    Wiecek A
    Clin Nephrol; 1996 Oct; 46(4):277-9. PubMed ID: 8905220
    [No Abstract]   [Full Text] [Related]  

  • 36. Parathyroid hormone, chronic renal failure and the liver.
    Massry SG; Smogorzewski M
    Kidney Int Suppl; 1997 Nov; 62():S5-7. PubMed ID: 9350669
    [No Abstract]   [Full Text] [Related]  

  • 37. Current status of the role of parathyroid hormone in uremic toxicity.
    Massry SG
    Contrib Nephrol; 1985; 49():1-11. PubMed ID: 3007022
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management.
    Fukagawa M; Kitaoka M; Kurokawa K
    Kidney Int Suppl; 1997 Nov; 62():S60-4. PubMed ID: 9350683
    [No Abstract]   [Full Text] [Related]  

  • 39. [Deleterious effects of parathormone on the heart].
    Ritz E; Nourrit-Poirette F
    Nephrol Ther; 2011 Feb; 7(1 Suppl 1):H13-6. PubMed ID: 21511202
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular complications in chronic renal failure.
    Massry SG
    Contrib Nephrol; 1987; 54():177-89. PubMed ID: 3552432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.